Atorvastatin-Curcuminoids Co-Treatment Suppresses ApoB Secretion and Alters Lipid and Glucose Homeostasis in HuH-7 Cells
ATO-curcuminoid co-treatment suppressed ApoB secretion but was accompanied by increased intracellular lipid accumulation, altered glucose uptake and GLUT2 expression, and apoptosis, indicating a discordant hepatic response.